María Del Rocío Hernández-Morales, Sandra Maldonado-Castañeda, Eleazar Mancilla-Hernández, Irving Amaro-Zarate, Margarita Aguirre-Barbosa, Samara Nazarala-Sanchez
{"title":"[Frequency of clinical characteristics and factors associated with mortality in patients hospitalized for COVID-19 in Puebla, Mexico].","authors":"María Del Rocío Hernández-Morales, Sandra Maldonado-Castañeda, Eleazar Mancilla-Hernández, Irving Amaro-Zarate, Margarita Aguirre-Barbosa, Samara Nazarala-Sanchez","doi":"10.29262/ram.v69i2.1146","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mexico has a very high mortality rate from COVID19, risk factors, clinical manifestations of our population are unknown.</p><p><strong>Objective: </strong>To know risk factors for mortality from COVID19 in hospitalized patients of the Secretary of Health (SSA) Puebla, and clinical characteristics.</p><p><strong>Material and methods: </strong>Case-control, observational, retrospective, cross-sectional study in COVID-19 patients. 2 groups: COVID-19 patients who died and those who did not die.</p><p><strong>Results: </strong>502 patients, 314 men (62.5% CI95% 58-66%), 188 women (37.5% CI95% 33-42%), mean age 54.14 +13.8, interquartile range (IQR) 45-63, age interval 19 and 90 years, hospital stay (DEIH) 1-43 days, mean 9.8+7.8 days, median 8, IQR 4-13 days. Symptoms associated with mortality: dyspnea, chest pain, MR>1. Variables associated with mortality: age = or > 65 years, greater IHD, having > 2 comorbidities (OR 1.453), diabetes (OR 1.759), hypertension (OR 6.29) and chronic kidney failure (CRF) (OR 3.16) , (p<0.05). Ferritin >500ng/ml (OR 5.1799), DHL >400 IU/L (OR 3.313) and D-dimer >2000 m/ml (OR 2.868).</p><p><strong>Conclusions: </strong>Age > or = 65 years, greater IHD, > 2 comorbidities, diabetes, hypertension or CRF, increased ferritin, D-dimer or DHL, are risk factors for mortality from COVID-19.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"69 2","pages":"67-71"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista alergia Mexico","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29262/ram.v69i2.1146","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Mexico has a very high mortality rate from COVID19, risk factors, clinical manifestations of our population are unknown.
Objective: To know risk factors for mortality from COVID19 in hospitalized patients of the Secretary of Health (SSA) Puebla, and clinical characteristics.
Material and methods: Case-control, observational, retrospective, cross-sectional study in COVID-19 patients. 2 groups: COVID-19 patients who died and those who did not die.
Results: 502 patients, 314 men (62.5% CI95% 58-66%), 188 women (37.5% CI95% 33-42%), mean age 54.14 +13.8, interquartile range (IQR) 45-63, age interval 19 and 90 years, hospital stay (DEIH) 1-43 days, mean 9.8+7.8 days, median 8, IQR 4-13 days. Symptoms associated with mortality: dyspnea, chest pain, MR>1. Variables associated with mortality: age = or > 65 years, greater IHD, having > 2 comorbidities (OR 1.453), diabetes (OR 1.759), hypertension (OR 6.29) and chronic kidney failure (CRF) (OR 3.16) , (p<0.05). Ferritin >500ng/ml (OR 5.1799), DHL >400 IU/L (OR 3.313) and D-dimer >2000 m/ml (OR 2.868).
Conclusions: Age > or = 65 years, greater IHD, > 2 comorbidities, diabetes, hypertension or CRF, increased ferritin, D-dimer or DHL, are risk factors for mortality from COVID-19.